| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/09/2008 | CN101214266A Paecilomyces hepiali mycelium mixed powder and preparation |
| 07/09/2008 | CN101214265A Chinese cephalosporin cordyceps sinensis mixed powder and preparation method |
| 07/09/2008 | CN101214232A Lutein micropills and preparation thereof |
| 07/09/2008 | CN101214105A Chinese herbal medicine health care cushion and preparation thereof |
| 07/09/2008 | CN101214053A Health-care beverage |
| 07/09/2008 | CN101214029A Processing and selling novel technique for dinner and secondary dinner dietotherapeutic adding food jujube product |
| 07/09/2008 | CN100401059C Fingerprint atlas quality investigating method of ginkgo lactone material |
| 07/09/2008 | CN100400535C Adiponectin expression promoter |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400515C Isoquinoline derivatives and methods of use thereof |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 07/09/2008 | CN100400116C Endoluminal prosthesis comprising a therapeutic agent and its use |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400074C Chinese medicinal preparation for freating coronary heart disease, brain arteriosclerosis and its preparation method |
| 07/09/2008 | CN100400064C Glucoside compound preparation and its preparing process |
| 07/09/2008 | CN100400055C Hotseason grow corydaline, its preparation method and its medicinal composition |
| 07/09/2008 | CN100400054C Compound injection from Chunxiongqin and Sanchi general saponin and its preparation |
| 07/09/2008 | CN100400051C Medicinal composition, and its preparing method and use |
| 07/09/2008 | CN100400047C Medicine powder for injection for treating cardiac and cerebral vascular diseases and its preparing method and application |
| 07/09/2008 | CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/09/2008 | CN100400037C Medicine composition containing borneol and musk |
| 07/08/2008 | US7396946 Compound for treatment of external secretion disorders |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396850 Pyrazole derivative as PPAR modulator |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396816 Low-molecular weight peptides inhibiting ion channel activity |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396545 Preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2424000C Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/08/2008 | CA2368775C Treatment of cardiovascular and related pathologies |
| 07/08/2008 | CA2360754C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 07/08/2008 | CA2330719C Synergistic compositions comprising an ascorbate and lysine for states related to extra cellular matrix degeneration |
| 07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
| 07/08/2008 | CA2229228C Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine |
| 07/08/2008 | CA2187444C Antirestenosis protein |
| 07/08/2008 | CA2162587C Therapeutic inhibitor of vascular smooth muscle cells |
| 07/08/2008 | CA2117782C Use of renin-angiotensin antagonist for reducing post myocardial infarct morbidity and mortality |
| 07/03/2008 | WO2008080012A1 Reduction of cardiovascular symptoms |
| 07/03/2008 | WO2008079995A2 Conjugate of natriuretic peptide and antibody constant region |
| 07/03/2008 | WO2008079687A1 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079139A1 Abca1 elevating compounds |
| 07/03/2008 | WO2008078785A1 Klf5 suppressor and method for selecting active ingredient of the medicament |
| 07/03/2008 | WO2008078729A1 Method for improving dissolution property |
| 07/03/2008 | WO2008078728A1 Ascorbic acid-containing pharmaceutical composition |
| 07/03/2008 | WO2008078727A1 Pharmaceutical composition having improved dissolution property |
| 07/03/2008 | WO2008078726A1 Solid preparation |
| 07/03/2008 | WO2008078725A1 Thiazepine derivative |
| 07/03/2008 | WO2008078420A1 Anti-arteriosclerotic agent |
| 07/03/2008 | WO2008078095A1 Treatment of macular degeneration |
| 07/03/2008 | WO2008077916A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/03/2008 | WO2008077810A2 Spiro-piperidine derivatives |
| 07/03/2008 | WO2008077556A1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
| 07/03/2008 | WO2008077554A1 Cycloalkylamine substituted isoquinoline derivatives |
| 07/03/2008 | WO2008077553A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 07/03/2008 | WO2008077552A1 Substituted isoquinoline and isoquinolinone derivatives |
| 07/03/2008 | WO2008077550A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
| 07/03/2008 | WO2008077247A1 Coatings for implantable medical devices comprising cholesterol |
| 07/03/2008 | WO2008077236A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | WO2008055092A3 Use of enoxaparin sodium for treating patients with acute ischemic stroke |
| 07/03/2008 | WO2008054825A9 Mixed cell populations for tissue repair and separation technique for cell processing |
| 07/03/2008 | WO2008054594A3 Method for controlling angiogenesis in animals |
| 07/03/2008 | WO2008052671A3 Combination therapy of substituted oxazolidinones |
| 07/03/2008 | WO2008033304A3 Compositions for promoting non-leaky collateral vascularization |
| 07/03/2008 | WO2008013743A3 Methods for inhibiting reperfusion injury |
| 07/03/2008 | WO2006134494A3 Anti-connexin compounds and therapeutic uses thereof |
| 07/03/2008 | US20080161406 Novel formulations of alpha-2,4-disulfophenyl-N-tert-butylnitrone |
| 07/03/2008 | US20080161400 Use of forms of propofol for treating diseases associated with oxidative stress |
| 07/03/2008 | US20080161386 increasing blood flow in brain vasculature with polyphenols such as flavanols, procyanidins; mixture of catechin, epicatechin, and (hydrophenyl-hydrochromene) derivatives; brain activation confirms by NMR images |
| 07/03/2008 | US20080161373 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 07/03/2008 | US20080161372 Methods for the Treatment of Hypertension |
| 07/03/2008 | US20080161358 Cyanoamide Compounds Useful as Malonyl-COA Decarboxylase Inhibitors |
| 07/03/2008 | US20080161354 Stable s-nitrosothiols, method of synthesis and use |
| 07/03/2008 | US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161347 Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use |
| 07/03/2008 | US20080161327 Substituted 9-Alkyladenines and the Use Thereof |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161323 Piperazine Derivatives of Alkyl Oxindoles |
| 07/03/2008 | US20080161321 Use of Renin Inhibitors in Therapy |
| 07/03/2008 | US20080161313 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide; retin inhibitor with other active ingredients; cardiovascular diseases and renal insufficiency |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161308 e.g. 4-[6-(2-cyclohexylethoxy)-3-oxoindan-5-yloxy]butanoic acid; peroxisome proliferator-activated receptor (PPAR) gamma agonist; antiinflammatory, antidiabetic agent; dyslipidaemia, atherosclerosis, insulin resistance |
| 07/03/2008 | US20080161304 e.g. 1'-(1-Benzothien-2-ylcarbonyl)-3H-spiro[2-benzofuran-1,4'-piperidine]; vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 07/03/2008 | US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity |
| 07/03/2008 | US20080161298 Spiro-piperidine derivatives |
| 07/03/2008 | US20080161297 Rho kinase inhibitors |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161286 excellent purity; bradycardic agent; myocardial ischaemia: angina pectoris, myocardial infarct, arrhythmia disturbances, heart failure; structure confirms by X-ray diffraction data; industrial scale, storage stability |
| 07/03/2008 | US20080161285 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |